PRGO
$69.95
Perrigo
($1.90)
(2.64%)
PRGO
Earnings Whisper ®
N/A
1st Quarter March 2017
Consensus:  $0.98
Revenue:  N/A
Monday
Aug 21
6:25 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Monday, May 22, 2017
Latest EPS
Monday, May 22, 2017

What do you expect when PRGO reports earnings?
Beat
Meet
Miss

Where is PRGO's stock price going from here?
Up
Flat
Down
Stock chart of PRGO
Analysts
Summary of analysts' recommendations for PRGO
Score
Grade
Pivots
Resistance
$73.38
$72.65
$71.30

$70.57

Support
$69.22
$68.49
$67.14
Tweet
Growth
Description
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalCelgeneJohnson & JohnsonEli LillyPfizerVertex PharmaceuticalsEndo International plcUltragenyx PharmaceuticalBristol-Myers Squibb